Supercharge Your Innovation With Domain-Expert AI Agents!

A method for rapid preparation of multiple anti-antibiotic hybridoma monoclonal antibodies

A technology of monoclonal antibodies and antibiotics, applied in chemical instruments and methods, hybrid peptides, animal/human proteins, etc., can solve problems such as antibiotic residues, difficulty in implementation, and difficulty in obtaining anti-antibiotic monoclonal antibody hybridoma cell lines , to achieve strong specificity, save time and cost

Active Publication Date: 2016-06-08
NINGBO ACCUTECH BIOSCI LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the small-scale and scattered characteristics of milk production in my country, it is difficult to implement the "Industrial Standards for Pollution-free Food Fresh Milk Industry", resulting in the problem of antibiotic residues in milk and dairy products in my country. The problem of milk safety is still a huge problem. question
Although the technology of immunizing mice with multiple antigens to produce multiple antibodies has been established, for the preparation of anti-antibiotic monoclonal antibodies, immunizing mice with multiple antibiotic carrier protein conjugates at the same time, due to the excessive amount of carrier protein Large, it is easy to form immune tolerance of mice to carrier protein, and the immunosuppressive effect of carrier protein inhibits the immune response of mice to antibiotics, thus leading to a decrease in the titer of anti-antibiotic antibodies, and it is difficult to obtain anti-antibiotic monoclonal antibody hybridization tumor cell line

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for rapid preparation of multiple anti-antibiotic hybridoma monoclonal antibodies
  • A method for rapid preparation of multiple anti-antibiotic hybridoma monoclonal antibodies
  • A method for rapid preparation of multiple anti-antibiotic hybridoma monoclonal antibodies

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] The preparation of embodiment 1 antibiotic-carrier protein conjugate

[0026] For the cross-linking of antibiotics and KLH EDC CarrierProteinKits (ThermoScientific) was completed, and the specific operation was carried out according to the instructions. Briefly, 10 mg of KLH is dissolved in 1 mL of water to make a 10 mg per mL solution. 2 mg each of penicillin, streptomycin, tetracycline, oxytetracycline and gentamycin were dissolved in 2.25 ml of 0.1 MMES, 0.9 M NaCl, 0.02% sodiumazide, pH 4.7 buffer. Add KLH solution and antibiotic solution to a 15 ml centrifuge tube, mix well, then add 250 microliters of EDC with a concentration of 10 mg / ml to the reaction solution, mix well, and react at room temperature for 2 hours in the dark. Purify and isolate the antibiotic-KLH conjugate with the attached purification column.

Embodiment 2

[0027] Embodiment 2 Preparation of anti-antibiotic monoclonal antibody hybridoma cells

[0028] The prepared solution of complete Freund's adjuvant and antibiotic-carrier protein conjugate was mixed at a ratio of 1:1 to make an emulsion. Female Balb / c mice aged 6-8 weeks were immunized by subcutaneous multi-point injection (200 microliters per mouse, about 40 microliters per point). Two weeks later, the mice were boosted with multi-point subcutaneous injection of antibiotic-carrier protein conjugates in incomplete Freund's adjuvant. Two weeks later, blood was taken to determine the titer of antibodies. The mice were immunized by injecting antibiotic-carrier protein conjugates through the tail vein. Four days later, the mice were sacrificed, the spleen cells were isolated, and the isolated spleen cells were fused with mouse myeloma cells SP2 / 0 cells with 50% PEG. Then, selection culture was carried out in HAT-containing medium. Only confluent cells survive in HAT medium.

Embodiment 3

[0029] Example 3 Screening of Antibiotic Monoclonal Antibody Hybridoma Cells

[0030]Dissolve 100 microliters of antibiotic-bovine serum albumin conjugates (penicillin-bovine serum albumin, streptomycin-bovine serum albumin, tetracycline-bovine serum albumin, soil Mycin-Bovine Serum Albumin, Gentamicin-Bovine Serum Albumin, the above-mentioned antibiotic-Bovine Serum Albumin conjugates were purchased from SIGMA Company) were added to the small wells of the 96-well microtiter plate, and placed overnight at 4°C . On the second day, wash the antibiotic-bovine serum albumin-bound 96-well microtiter plate with washing solution (PBS buffer containing 0.05% Tween) twice. Then the microtiter plate was blocked with blocking solution (1%BSA / washing solution) at room temperature for two hours. The blocking solution was poured off, and then 100 microliters of the cell culture supernatant was added to a 96-well plate with the hybridoma culture solution obtained in Example 2, incubated at...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
affinityaaaaaaaaaa
Login to View More

Abstract

The invention discloses a novel method for quickly and efficiently preparing a plurality of antibiotic-resistant hybridoma monoclonal antibodies in a time-saving manner. The method comprises the following concrete steps: (1) covalently linking different antibiotics to a same protein carrier, and immunizing a mouse with a cross-linked antibiotic protein conjugate; (2) separating spleen cells of the mouse, fusing the spleen cells of the mouse with myeloma cells SP2 / 0 of the mouse, and performing selective culture; (3) screening out positive hybridoma cell strains for producing different antibiotic-resistant monoclonal antibodies, and storing respectively; (4) preparing single antibiotic-resistant monoclonal antibody from the different hybridoma cell strains in the step (3). According to the method, the monoclonal antibodies resistant to different antibiotics can be obtained through one-time fusing at the same time, so that the preparation time of the monoclonal antibodies is greatly shortened and the preparation cost of the monoclonal antibodies is greatly reduced.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to an antibiotic protein conjugate and a novel method for preparing various anti-antibiotic hybridoma monoclonal antibodies rapidly, efficiently and time-savingly using the conjugate. Background technique [0002] Milk is a nutritional product suitable for all ages, but with the widespread use of antibiotics in dairy farming, the issue of antibiotic residues in milk has drawn increasing attention from the international community. In 1991, the U.S. Food and Drug Administration (FDA) tested 234 fresh milk samples and found only one sample had residues of the antibiotic sulfamethazine. In the first half year of 1992, among the 197 fresh milk samples of the U.S. Food and Drug Administration (FDA), 4 samples had antibiotic sulfonamide residues. European and American countries stipulate that milk and its dairy products that exceed the allowable standard are all discarded and must...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/765C07K14/77C07K14/795C07K14/75C07K14/47C07K14/465C07K16/44
CPCC07K14/47C07K14/4717C07K14/75C07K14/765C07K14/77C07K14/795C07K16/44C07K19/00
Inventor 赖增祖叶欣徐健杨奎东赖晓娟
Owner NINGBO ACCUTECH BIOSCI LTD
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More